Metabolomic and Mitochondrial Fingerprinting of the Epithelial-to-Mesenchymal Transition (EMT) in Non-Tumorigenic and Tumorigenic Human Breast Cells.

Cuyàs, Elisabet; Fernández-Arroyo, Salvador; Verdura, Sara; Lupu, Ruth; Joven, Jorge; Menendez, Javier A

Cuyàs, Elisabet; Fernández-Arroyo, Salvador; Verdura, Sara; Lupu, Ruth; Joven, Jorge; Menendez, Javier A.

Afiliação

Cuyàs E; Metabolism and Cancer Group, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology, 17005 Girona, Spain.
Fernández-Arroyo S; Girona Biomedical Research Institute, 17190 Girona, Spain.
Verdura S; Eurecat, Centre Tecnològic de Catalunya, Centre for Omic Sciences, Joint Unit Eurecat-Universitat Rovira I Virgili, Unique Scientific and Technical Infrastructure (ICTS), 43204 Reus, Spain.
Lupu R; Metabolism and Cancer Group, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology, 17005 Girona, Spain.
Joven J; Girona Biomedical Research Institute, 17190 Girona, Spain.
Menendez JA; Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, MN 55905, USA.

Cancers (Basel) ; 14(24)2022 Dec 16.

Article em En | MEDLINE | ID: mdl-36551699

Palavras-chave

breast cancer; complex III; metabolism; mitochondria; phenotypic screening; therapy resistance

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google